Sapiens Intl Cp Nv (SPNS) 12.78 $SPNS Sapiens Names

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Sapiens Intl Cp Nv (SPNS) 12.78 $SPNS

Sapiens Names Andre M. Boisvert Chairman of Sapiens DECISION Board of Directors
PR Newswire - Thu Jul 28, 8:12AM CDT
Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the financial services sector, announced today that veteran software industry executive, private investor and technology consultant Andre M. Boisvert was nominated to serve as the chairman of the board of directors of Sapiens DECISION.
SPNS: 12.78 (-0.06), ISDR: 7.20 (+0.05), SGNT: 21.69 (+0.02)

Sapiens Partners with Life.io to Enhance its Digital Suite and Help Insurers Better Engage with Customers
PR Newswire Europe - Tue Jul 26, 7:46AM CDT
HOLON, Israel, July 26, 2016 /PRNewswire/ --
SPNS: 12.78 (-0.06)

Sapiens to Announce Second Quarter 2016 Financial Results on August 4, 2016
PR Newswire - Mon Jul 18, 5:35AM CDT
Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, announced today that it will report its financial results for the second quarter that ended on June 30, 2016 on Thursday, August 4, 2016.
SPNS: 12.78 (-0.06)

MLOZ in Production with Sapiens IDIT Solution
PR Newswire Europe - Tue Jun 14, 1:46AM CDT
HOLON, Israel, June 14, 2016 /PRNewswire/ --
SPNS: 12.78 (-0.06)

Sapiens Acquires Maximum Processing, a North American P&C Solution Provider
PR Newswire - Tue Jun 07, 8:19AM CDT
Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, announced today that it has entered into a definitive agreement for the acquisition of Maximum Processing, Inc., the software provider of the Stingray System, a property and casualty (P&C) insurance administration suite targeted towards the tier 4-5 U.S. market, as well as managing general agents (MGAs), third-party administrators (TPAs) and insurance brokers. The transaction is expected to close by the end of June 2016.
SPNS: 12.78 (-0.06)

Sapiens Announces Significant Expansion of its North American Presence
PR Newswire - Wed May 25, 6:52AM CDT
Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, announced today that it has significantly increased its investment in its North American insurance and retirement services practice.
SPNS: 12.78 (-0.06)

Anadolu Insurance Company Signs a Multi-Million Dollar Agreement with Sapiens, Expanding Their Strategic Relationship
PR Newswire Europe - Mon May 23, 2:52AM CDT
HOLON, Israel, May 23, 2016 /PRNewswire/ --
SPNS: 12.78 (-0.06)

Sapiens Reports 20.9% Revenue Growth in Q1 2016
PR Newswire - Tue May 10, 3:07AM CDT
Sapiens International Corporation (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, and a member of the Formula Group (NASDAQ and TASE: FORTY), today announced its financial results for the first quarter ended March 31, 2016.
SPNS: 12.78 (-0.06), FORTY: 37.24 (+0.75)

Sapiens to Present at the 44th Annual J.P. Morgan Global Technology, Media and Telecom Conference
PR Newswire - Mon May 09, 7:38AM CDT
Sapiens International Corporation (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, today announced that the company will present at the 44th Annual J.P. Morgan Global Technology, Media and Telecom Conference, to be held at The Westin Copley Place in Boston, Massachusetts, on May 23-25, 2016. Sapiens CEO Roni Al-Dor will present on Wednesday, May 25 at 10:00 (EST). Sapiens' senior management will be available for one-on-one, or group meetings with investors throughout the conference.
SPNS: 12.78 (-0.06), JPM: 63.97 (-0.13)

Tech Stocks to Report Earnings on May 10: NUAN, NEWR, SPNS
Zacks Equity Research - Zacks Investment Research - Mon May 09, 7:19AM CDT
Among the companies slated to report this week, let's see what's ahead for these three tech stocks ??? Nuance Communications, Sapiens International and New Relic ??? all of which are scheduled to release their quarterly numbers on May 10.
NEWR: 34.44 (-0.56), SPNS: 12.78 (-0.06), NUAN: 16.07 (+0.09), GOOGL: 791.34 (+25.50), MSFT: 56.68 (+0.47), AAPL: 104.21 (-0.13)

Sapiens Introduces Enhanced Version of DECISION Manager
PR Newswire - Wed May 04, 2:49AM CDT
Sapiens International Corporation, (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the financial services sector, today announced the introduction of the latest and enhanced version of Sapiens DECISION Manager, a key component of its Business Decision Management solution, Sapiens DECISION Suite.
SPNS: 12.78 (-0.06)

Two Sapiens P&C Customers Receive Celent Model Insurer Awards
PR Newswire Europe - Mon Apr 25, 3:36AM CDT
HOLON, Israel, April 25, 2016 /PRNewswire/ --
SPNS: 12.78 (-0.06)

Sapiens to Announce First Quarter 2016 Financial Results on May 10, 2016
PR Newswire - Wed Apr 20, 5:26AM CDT
Sapiens International Corporation (NASDAQ and TASE: SPNS), a leading global provider of software solutions for the insurance industry, with a growing presence in the financial services sector, announced today that it will report its financial results for the first quarter that ended on March 31, 2016 on Tuesday, May 10, 2016.
SPNS: 12.78 (-0.06)

Sapiens to Present at the Jefferies 2016 Technology Conference
PR Newswire Europe - Tue Apr 19, 6:42AM CDT
HOLON, Israel, April 19, 2016 /PRNewswire/ --
SPNS: 12.78 (-0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Updated Category News Views 21

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Continue Reading
Paradigm Therapeutics: A Beacon in Rare Diseases

Updated Category News Views 4

A Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...

Continue Reading
Partner Valuation Advisors Bolsters Team with Eichman

Updated Category News Views 7

Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...

Continue Reading
Skiptown Expands in Georgia Amid Growing Demand

Updated Category News Views 24

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Continue Reading
Think Tank Pushes for Bold Parkinson's Prevention Plan

Updated Category News Views 25

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

Continue Reading
Veterans Transitioning to Real Estate with Scholarships

Updated Category News Views 15

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Continue Reading
Special Needs Group Partners with MAST to Enhance Accessibility

Updated Category News Views 22

Accessible Travel Takes the Spotlight Ah, the travel biz—just when you think you’ve got it all figured out, along comes a partnership like this to shake things up. Special Needs Group, the big cheese in mobility and medical equipment rentals, is teaming up with MAST Travel Network. Together, they're rolling out initiatives to make the world a bit more accessible, even...

Continue Reading
Omneky Outshines Competitors in AI Ad Scoring

Updated Category News Views 33

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 16

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 7

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading

Top 5 Most Recently Viewed Articles

Pieridae Energy Limited Reports Strong Q3 2024 Performance

Updated Category News Views 58

Strong Financial and Operational Results from Pieridae Energy CALGARY, Alberta - Pieridae Energy Limited (“Pieridae” or the “Company”) (TSX: PEA) has announced its third quarter 2024 financial and operating results, showcasing an impressive production output and robust financial performance. The company achieved a production rate of 23,116 barrels of oil...

Continue Reading
Atea Pharmaceuticals Showcases Promising HCV Treatment Data

Updated Category News Views 136

Innovation in Hepatitis C Treatment by Atea Pharmaceuticals Atea Pharmaceuticals, Inc. (NASDAQ: AVIR) has made a significant impact in the field of antiviral therapeutics through their ongoing research and development efforts. The company recently presented compelling data at The Liver Meeting 2024, highlighting the promising combination of bemnifosbuvir and ruzasvir for...

Continue Reading
Study Confirms Safety of Combined Eye Drops for Surgery Use

Updated Category News Views 172

Introduction to the Study A five-year pharmacovigilance study has confirmed the excellent safety profile of a fixed-dose combination eye drop developed by NTC. This eye drop combines an anti-inflammatory steroid and a quinolone antibiotic, designed for preventing and treating inflammation, as well as preventing infection after cataract surgery. Study Overview The findings...

Continue Reading
New Concerns Arise for Roblox Amid Allegations of Misreported Metrics

Updated Category News Views 203

Allegations Against Roblox: A Closer Look Roblox Corp (NYSE: RBLX) has recently come under fire after a report from Hindenburg Research highlighted potential discrepancies in its reported user metrics, leading to a notable decline in its stock prices. The gaming platform is being questioned for allegedly overstating its user metrics, including daily active users (DAUs)...

Continue Reading
uniQure N.V. Faces Investigation Amid Securities Fraud Concerns

Updated Category News Views 155

Understanding the uniQure N.V. Investigation Currently, uniQure N.V. is under investigation concerning possible violations of securities laws. This inquiry has raised significant concerns for shareholders and potential investors, driving many to seek assistance in understanding their rights moving forward. The investigation is being led by the DJS Law Group, an...

Continue Reading